Scripps calls off controversial merger talks with USC; Rottapharm calls off IPO; Sandoz to move U.S. HQ;

@FierceBiotech: Wall Street wonders what Shire is worth. Report | Follow @FierceBiotech

@JohnCFierce: Merck vet steps in to lead Third Rock's immuno-oncology upstart. Item | Follow @JohnCFierce

@DamianFierce: $SRPT and DMD docs are upbeat on 144-week eteplirsen data, but shares are down about 10%. Article | Follow @DamianFierce

@EmilyMFierce: Faculty calls for removal of Scripps' leader amid USC merger talks. FierceBiotech Research story | Follow @EmilyMFierce

Facing some stiff opposition from staff scientists, Scripps Research Institute has called off talks with USC about a possible merger. The talks were triggered by a large operating deficit and declining NIH grants, a trend that has rattled a number of top research centers. But Scripps faculty responded to the prospect of a merger by calling for the ouster of President Michael Marletta, saying that they've lost confidence in his leadership abilities. Release

Italy's Rottapharm Madaus has scrapped plans for an IPO, responding to a dwindling appetite for new offerings and a full banquet to choose from. Story

Sandoz is moving to a new U.S. base in New Jersey, taking over a building vacated by Novo Nordisk ($NVO) a year ago. Story

Medical Device News

@FierceMedDev: We're looking for the fiercest companies in med tech for our 2014 Fierce 15 awards. More details here | Follow @FierceMedDev

@StacyALawrence: Zimmer, Biomet hit regulatory speedbump in pending merger. Story | Follow @StacyALawrence

@VarunSaxena2: JAMA study adds to robotic surgery safety concerns. Article | Follow @VarunSaxena2

@MichaelGFierce: MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. FierceDrugDelivery story| Follow @MichaelGFierce

@EmilyWFierce: FDA laid out its new strategic plan for developing therapies for rare childhood diseases. PMLiVE article | Follow @EmilyWFierce

USGI Medical fills enrollment for pivotal U.S. study of its incisionless, endoscopic weight loss procedure. Story

FDA clears oral sleep apnea device as search for alternatives to CPAP therapy continues. Report

Gynesonics aims for $35M for minimally invasive uterine fibroid device. Article

Pharma News

@FiercePharma: ICYMI: This week's issue of FiercePharmaMarketing. Report | Follow @FiercePharma

@EricPFierce: Health Canada tells GSK to get its vaccine house in order as flu season approaches. More | Follow @EricPFierce

@CarlyHFierce: M&A spotlight: Allergan plots cost cuts to ward off Valeant, AbbVie may have to raise Shire bid--again. Story | Follow @CarlyHFierce

NICE likes Lundbeck's alcohol-addiction drug Selincro. Article

Insurers balk at pricey generic version of ancient GSK heart drug. Story

Vaccines News

U.S. bioterror readiness highlighted after NIH smallpox discovery. Article

Could soaring vaccine prices spark Sovaldi-style payer pushback? Story

No link between Merck's Gardasil and blood clots, study says. Item

Report: Manufacturing, logistical challenges to weigh down cancer vaccine market through 2022. More

Canada gives GSK 30-day deadline for turnaround plans at FluLaval plant. Article

Pharma Manufacturing News

Report: Dendreon's costly manufacturing casts doubt on cancer vax viability. Article

Portfolio trimming by generic manufacturers linked to soaring drug costs. Item

Global CMOs tipped to enter Russia as local drug production deadline nears. Story

Serum Institute allies with biotech in bid to cut cost of biosimilar production. More

India faces higher QC costs as Shasun shows value of compliance. Article

U.K. commits cash to $24.7M industry-focused formulation center. Story